News
Merck has characterized its cost-cutting initiative as more of a reallocation of resources to support other, higher-growth ...
Facing patent expiration for its blockbuster Keytruda, Merck aims to streamline operations with significant job cuts and ...
Merck (MRK) may be a storied pharmaceutical giant with a 134-year history, but it still has a lot of room to run. Merck is ...
9h
24/7 Wall St. on MSNHigh Noon Admits Major Labeling Error, Plus Recalled Products with Catastrophic ImpactsRecalls happen most every day, but some can be more impactful than others. These are the most major recalls in recent history ...
The Schwab dividend ETF is a solid pick, but some stocks might offer more upside. Philip Morris International is delivering ...
Halal Food Ingredients Market Halal food ingredients market was valued at $58.4 billion in 2023, and is estimated to reach $108.9 billion b ...
It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough ...
President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...
President Donald Trump surprised pharma CEOs on Thursday with letters demanding they acquiesce to his most-favored ...
U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results